About Cabling Installation & Maintenance

Our mission: Bringing practical business and technical intelligence to today's structured cabling professionals

For more than 30 years, Cabling Installation & Maintenance has provided useful, practical information to professionals responsible for the specification, design, installation and management of structured cabling systems serving enterprise, data center and other environments. These professionals are challenged to stay informed of constantly evolving standards, system-design and installation approaches, product and system capabilities, technologies, as well as applications that rely on high-performance structured cabling systems. Our editors synthesize these complex issues into multiple information products. This portfolio of information products provides concrete detail that improves the efficiency of day-to-day operations, and equips cabling professionals with the perspective that enables strategic planning for networks’ optimum long-term performance.

Throughout our annual magazine, weekly email newsletters and 24/7/365 website, Cabling Installation & Maintenance digs into the essential topics our audience focuses on.

  • Design, Installation and Testing: We explain the bottom-up design of cabling systems, from case histories of actual projects to solutions for specific problems or aspects of the design process. We also look at specific installations using a case-history approach to highlight challenging problems, solutions and unique features. Additionally, we examine evolving test-and-measurement technologies and techniques designed to address the standards-governed and practical-use performance requirements of cabling systems.
  • Technology: We evaluate product innovations and technology trends as they impact a particular product class through interviews with manufacturers, installers and users, as well as contributed articles from subject-matter experts.
  • Data Center: Cabling Installation & Maintenance takes an in-depth look at design and installation workmanship issues as well as the unique technology being deployed specifically for data centers.
  • Physical Security: Focusing on the areas in which security and IT—and the infrastructure for both—interlock and overlap, we pay specific attention to Internet Protocol’s influence over the development of security applications.
  • Standards: Tracking the activities of North American and international standards-making organizations, we provide updates on specifications that are in-progress, looking forward to how they will affect cabling-system design and installation. We also produce articles explaining the practical aspects of designing and installing cabling systems in accordance with the specifications of established standards.

Cabling Installation & Maintenance is published by Endeavor Business Media, a division of EndeavorB2B.

Contact Cabling Installation & Maintenance

Editorial

Patrick McLaughlin

Serena Aburahma

Advertising and Sponsorship Sales

Peter Fretty - Vice President, Market Leader

Tim Carli - Business Development Manager

Brayden Hudspeth - Sales Development Representative

Subscriptions and Memberships

Subscribe to our newsletters and manage your subscriptions

Feedback/Problems

Send a message to our general in-box

 

Massive Bio Unveils Groundbreaking Oncology/Hematology AI Platform at ASCO 2024: Revolutionizing Oncology/Hematology with AI Driven Personalized Insights for Clinical Trial Accessibility

At the forefront of oncological/hematological innovation, Massive Bio, Inc. is set to showcase its pioneering AI technology at the ASCO Annual Meeting 2024, highlighting a major leap in patient and physician engagement in cancer care. The company will unveil its latest advancements in the Massive Bio Deep Learning Clinical Trial Matching System (DLCTMS, aka Synergy-AI), an AI platform designed to transform how cancer clinical trials are accessed and managed globally by structuring vast oncological/hematological data and personalizing patient trial matches in real time.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240507335842/en/

Massive Bio, ASCO 2024 (Graphic: Business Wire)

Massive Bio, ASCO 2024 (Graphic: Business Wire)

Selin Kurnaz, PhD, CEO of Massive Bio, states, “At Massive Bio, our mission transcends traditional clinical trial matching. With our AI-driven system, we’re not just facilitating connections; we’re revolutionizing how oncologists/hematologists, patients, and trials interact. Synergy-AI epitomizes our commitment to harnessing cutting-edge technology to expedite R&D and enhance patient care, ensuring that every cancer patient has access to the trials they need, when they need them. With more than 120,000 patients, 5,000 physicians, 40 Pharma and CRO Customers, and 50 Partners, we have been building the largest oncology/hematology network to transform patient recruitment at scale despite the fact that we are just starting to scratch the surface, our ambition is massive.”

Dr. Arturo Loaiza-Bonilla, Co-Founder and Chief Medical Officer at Massive Bio, adds, “Our platform does more than just match patients to trials. It integrates predictive analytics and real-time updates, making over 14,000 trials accessible within seconds. This not only maximizes trial enrollment potentials but also significantly cuts down on screen failures, ensuring that patients receive personalized care tailored to their specific conditions and preferences.”

Innovative Features and Global Impact:

  • Real-time, AI-driven Matching: Synergy-AI can analyze and summarize extensive medical records, including biomarker data from multiple sources, to match patients with clinical trials instantly.
  • Global Accessibility: Deployed via cloud to physician practices and research sites worldwide, including Europe, LATAM, and expanding into APAC, Synergy-AI supports a wide array of international compliance standards such as GDPR, PIPEDA, and HIPAA.
  • Extensive Collaborative Network: Massive Bio collaborates with top-tier pharma companies, CROs, advocacy groups, and other stakeholders in the healthcare ecosystem to enhance the societal impact of its innovations.
  • Enhanced Patient and Physician Interfaces: Building on the success of our chatbots Fiona AI and Dr Arturo AI, Massive Bio has further refined these tools to improve interactions, making the user experience more intuitive and supportive.

Invitation to Collaborate: Massive Bio is extending an open invitation to all ASCO 2024 attendees to visit booth #29137 to experience firsthand how Synergy-AI can transform their approach to cancer care and clinical trials. “Join us in advancing the future of oncology, where AI empowers more precise, efficient, and patient-centric clinical practices,” encourages Dr. Kurnaz.

With its unparalleled technology and comprehensive approach, Massive Bio is not just participating in the market—it's leading the way to a future where every cancer patient can access personalized, innovative care options, accelerating the journey towards a cure.

About Massive Bio:

Massive Bio’s vision is to cover entire Pharma value chain with disruptive solutions to improve entire ecosystem from drug development to commercialization. Massive Bio is a unique tech-enabled big data platform with multiple use cases — addressing all friction points in end-to-end patient journey, enabling access to advanced treatment options for patients and optimizing drug commercialization for pharma. Utilizing AI to enhance equitable access and precision targeting for clinical trial matching, drug matching, and drug development, Massive Bio is committed to breaking down barriers in clinical trial enrollment, fostering value-based oncology decisions, and facilitating data-driven cancer treatment. Serving over four dozen pharmaceutical companies, contract research organizations, and hospital networks, Massive Bio has earned recognition from the National Cancer Institute with an SBIR contract, and it is founding member of CancerX Moonshot. Founded in 2015 by a team of clinical, technology, and M&A executives, Massive Bio boasts a global presence with nearly 100 people across 12 countries. For further details, please visit www.massivebio.com, https://askfiona.ai, https://drarturo.ai or interact with us on our social media channels.

Contacts

Massive Bio

Erkan Terzi

Chief Marketing Officer

+1 844 627 7246 p

pr@massivebio.com

More News

View More

Recent Quotes

View More
Symbol Price Change (%)
AMZN  216.48
+3.44 (1.61%)
AAPL  262.24
+9.95 (3.94%)
AMD  240.56
+7.48 (3.21%)
BAC  52.04
+0.76 (1.48%)
GOOG  257.02
+3.23 (1.27%)
META  732.28
+15.37 (2.14%)
MSFT  516.79
+3.21 (0.63%)
NVDA  182.64
-0.58 (-0.32%)
ORCL  277.24
-14.07 (-4.83%)
TSLA  447.43
+8.12 (1.85%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.